|
![]() |
|||
|
||||
OverviewThis book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D). Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials. The book integrates information from human and animal studies. The book considers T1D within the broader context of autoimmune disease. The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure. Full Product DetailsAuthor: Gregory R. Bock , Jamie A. GoodePublisher: John Wiley & Sons Inc Imprint: John Wiley & Sons Inc Volume: 292 Dimensions: Width: 15.80cm , Height: 1.50cm , Length: 23.50cm Weight: 0.476kg ISBN: 9780470723258ISBN 10: 0470723254 Pages: 222 Publication Date: 13 June 2008 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock ![]() The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationThe Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research. Tab Content 6Author Website:Countries AvailableAll regions |